The mechanisms regulating receptor internalization are not well understood and vary among different G protein-coupled receptors. The bombesin (Bn)/gastrin-releasing peptide receptor GRP-R, which is coupled to phospholipase C via the G q family of transducing proteins, is internalized rapidly after Bn binding. Agonist stimulation leads to rapid receptor phosphorylation, as does activation of protein kinase C (PKC) by phorbol-12-myristate-13-acetate (PMA). However, agonist-and PMA-induced phosphorylation occur at different receptor sites. Here, we examined the role of PKC in GRP-R internalization after agonist and antagonist binding. We synthesized [D- ]Bn(6 -13)PA. Consistent with these observations, the treatment of cells with 100 nM Bn at 37°reduced cell surface receptors within minutes, whereas [D-Tyr 6 ]Bn(6 -13)PA had no effect. The addition of PMA did not induce the internalization of antagonist-occupied receptors, but pharmacological inhibition of PKC decreased the rate of agonist-induced receptor internalization. These results therefore demonstrate that although PKC contributes to agonist-induced internalization of the GRP-R, it does not elicit receptor internalization of the antagonist-occupied receptor.
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Ligand-induced receptor endocytosis is one of the mechanisms by which cells regulate receptor function; depleting the cell surface of receptors results in desensitization of the cellular response, whereas receptor recycling may play a role in receptor resensitization (Bohm et al., 1997; Koenig and Edwardson, 1997) . Despite its importance, the molecular signals required to initiate receptor internalization are not understood. For example, it is not clear how the nature of the bound ligand affects receptor endocytosis. Studies with select GPCRs indicated that agonist-occupied receptors are rapidly internalized while antagonist-occupied receptors remain on the cell surface after ligand binding (Bohm et al., 1997; Koenig and Edwardson, 1997) . In fact, agonist strength, as measured by the coupling efficiency of the agonist/receptor complex, correlates with the rate of agonist-induced sequestration of the ␤-adrenergic receptor (January et al., 1997) . However, studies with peptide-binding GPCRs have provided examples of antagonist-induced receptor internalization (Conchon et al., 1994; Roettger et al., 1997) , as well as agonist-induced receptor endocytosis that is unrelated to agonist potency (Keith et al., 1997 (Keith et al., , 1998 . Further complexity is introduced by the fact that second-messenger-activated kinases can modulate receptor internalization (Liles et al., 1986; Hoover and Toews, 1990; Fonseca et al., 1995) . In this study, we examined the role of the bound ligand and PKC activation in Bn receptor endocytosis.
The Bn family of structurally homologous peptides includes the two mammalian peptides GRP and neuromedin B and numerous amphibian homologs (Lebacq-Verheyden et al., 1990; Nagalla et al., 1996) . In mammals, Bn-like peptides are found in both the central and peripheral nervous systems, as well as in endocrine cells in a number of tissues, including the gastrointestinal tract and the lung (Sunday et al., 1988; Lebacq-Verheyden et al., 1990) . These peptides produce a diverse array of biological effects, including modulation of neuronal excitability and the regulation of smooth muscle contraction, cell proliferation, and exocrine and endocrine secretion, including pancreatic insulin release (Sunday et al., 1988; Lebacq-Verheyden et al., 1990) . Bn-like peptides also promote cell proliferation and function as autocrine growth factors involved in the pathogenesis of small cell lung cancer (Sunday et al., 1988; Lebacq-Verheyden et al., 1990) . Hence, Bn receptor antagonists are being vigorously investigated as inhibitors of tumor growth.
Three pharmacologically distinct Bn receptor subtypes have been cloned in mammals, all members of the GPCR family (Giladi et al., 1993; Kroog et al., 1995a) . The GRPpreferring receptor, GRP-R, previously called BR1, binds both GRP and Bn with nanomolar affinity but binds neuromedin B only 1% as well. In contrast, the neuromedin Bpreferring receptor binds neuromedin B with nanomolar affinity and GRP and Bn with 10-and 100-fold lower affinity, respectively. The BRS-3 receptor binds both GRP (K d Ϸ 300 nM) and neuromedin B (K d Ϸ 20 M) with low affinity, and a naturally occurring, high affinity ligand has not been identified for this receptor subtype (Gorbulev et al., 1992) .
HIT-T15 is a clonal line of transformed pancreatic cells that retains many characteristics of normal ␤ cells (Santerre et al., 1981) , including increased insulin secretion on Bn stimulation Schonbrunn, 1984, 1988) . Bn initiates this response by binding to specific membrane receptors with high affinity for GRP (Swope and Schonbrunn, 1987) , consistent with the known expression of the GRP-R in the pancreas (Battey et al., 1991) . In HIT-T15 cells, as in other responsive cell types, the GRP-R is coupled to PLC (Swope and Schonbrunn, 1988) via pertussis toxin-insensitive G proteins (Fischer and Schonbrunn, 1988) . Activation of PLC causes a rapid increase in two second messengers, inositol trisphosphate and diacylglycerol (Swope and Schonbrunn, 1988; Regazzi et al., 1990) , which leads to a rise in cytosolic Ca 2ϩ and PKC activation (Swope and Schonbrunn, 1988; Regazzi et al., 1990) . These two signaling pathways act synergistically to induce a burst of insulin secretion in response to Bn (Swope and Schonbrunn, 1988) . However, extended exposure to Bn results in desensitization and a loss in cell surface receptors, with the latter being at least partially responsible for the desensitization of HIT cells to further Bn stimulation (Swope and Schonbrunn, 1990) . Bn stimulation of insulin secretion, as well as Bn-induced inositol trisphosphate production and intracellular Ca 2ϩ elevation, also are desensitized after a 2-hr exposure of cells to the PKC activator PMA (Swope and Schonbrunn, 1990) . Although the complex molecular events involved in GRP-R desensitization are poorly understood, Bn binding and PKC activation by the phorbol ester PMA both stimulate the rapid phosphorylation of the GRP-R (Kroog et al., 1995b; Williams et al., 1996) . Interestingly, Bn-and PMA-stimulated phosphorylation occurs at distinct sites (Williams et al., 1996) . Moreover, results with truncated and chimeric GRP-Rs have suggested that activations of both PKC-and second-messenger-independent kinases are required for normal receptor endocytosis (Benya et al., 1993 (Benya et al., , 1994 . Nevertheless, the role in GRP-R endocytosis for agonist-induced conformational changes during receptor activation versus signal transduction involving PKC stimulation remains unclear.
To elucidate the mechanisms involved in Bn receptor internalization, we synthesized a potent Bn receptor antagonist that can be radiolabeled. In the current study, we compare receptor-mediated processing of this antagonist with that of agonist by the endogenously expressed GRP-R in the HIT-T15 cell line and examine the role of PKC in receptor internalization. ]Bn(6-13)PA. Peptide structure was verified by amino acid analysis and fast atom bombardment mass spectrometry. Peptide purity was determined by analytical reverse-phase high performance liquid chromatography and shown to be Ͼ95%.
Experimental Procedures

Materials
Cell culture. The establishment and properties of the HIT cell line have been described previously (Swope and Schonbrunn, 1984) . Cells were grown as monolayer cultures in F12 media supplemented with 15% horse serum and 2.5% fetal bovine serum. For insulin release and peptide-binding experiments, the cells were seeded at a density of 3 ϫ 10 5 cells/35-mm dish. The culture medium was changed every 3-4 days, and experiments were performed 1 day after a medium change. The cells were maintained for three to five medium changes before use.
Measurement of insulin secretion. Insulin release was determined as described previously Schonbrunn, 1988, 1990) . Briefly, cells were washed twice with HBSS, pH 7.2 (118 mM NaCl, 4.6 mM KCl, 0.5 mM CaCl 2 , 1 mM MgCl 2 , 10 mM glucose, 5 mM HEPES, 1 mg/ml bovine serum albumin, and 1 mg/ml NaHCO 3 ), and then incubated in a CO 2 incubator at 37°for 30 min. The buffer was replaced with 37°HBSS containing the appropriate concentration of peptide, and the cells were incubated for an additional 60 min. The buffer then was collected, centrifuged at 500 ϫ g for 10 min to remove any floating cells, and stored frozen. Radioimmunoassays were performed with guinea pig anti-insulin (porcine) serum as described previously (Swope and Schonbrunn, 1984 liquid chromatography to a specific activity of 2200 Ci/mmol as described previously (Williams and Schonbrunn, 1994) .
Binding studies were performed in ambient atmosphere as described previously (Swope and Schonbrunn, 1987 ]Bn was added to each dish to a final concentration of ϳ10 Ϫ11 M. At the end of the appropriate incubation period, the buffer was aspirated and the dishes were rapidly rinsed with ice-cold 0.15 M NaCl. The cells then were dissolved in 0.1 N NaOH, and the cell-associated radioactivity was determined in a Pharmacia LKB (St. Quentin, France) ␥ spectrometer at an efficiency of 75%. Specific binding was calculated as the difference between the amount of radioiodinated peptide bound in the absence (total binding) and the presence (nonspecific binding) of 100 nM Bn. Unless stated otherwise, the data shown represent specific binding and are given as the mean Ϯ standard error.
An acid wash procedure was used to determine the cellular distribution of bound [ 125 I-D-Tyr 6 ]Bn(6-13)PA and [ 125 I-Tyr 4 ]Bn (Swope and Schonbrunn, 1987) . After the binding incubation, cells were washed twice with ice-cold HBSS and treated for 5 min at 4°with 1 ml of 0.2 M acetic acid and 0.5 M NaCl, pH 2.5. Cells then were dissolved in 0.1 N NaOH, and the cell-associated radioactivity was determined.
To determine the effect of Bn and its analogs on receptor internalization, a milder acid wash procedure was used to dissociate unlabeled peptide before the binding reaction. Cells were preincubated with peptide at 37°for the indicated times to cause receptor internalization. The cells then were washed with ice-cold HBSS, treated for 5 min at 4°with 1 ml of HBSS containing 20 mM glycine, Chromatography of 125 I, 125 I-tyrosine, and 125 I-peptide. To determine the nature of the radioactivity associated with the cells after the binding of radioiodinated peptide, cells were rinsed twice with ice-cold HBSS and immediately extracted in 1 ml of 0.1 N HCl and 0.1% bovine serum albumin for 10 min at 4°or incubated in fresh HBSS for 1 hr at 37°. The nature of the radiolabeled material extracted from the cells or dissociated into the buffer was analyzed as described previously (Swope and Schonbrunn, 1987) . Briefly, samples were applied to Sep-Pak C 18 cartridges that had been washed with 5 ml of methanol followed by 10 ml of deionized water. Iodide ( 125 I Ϫ ), 125 I-tyrosine, and 125 I-peptides were sequentially eluted with 15 ml of 0.1% TFA, 15 ml of 25% methanol in 0.1% TFA, and 15 ml of 80% methanol in 0.1% TFA, respectively.
Data analysis. Data analysis was performed with the programs Multifit (Day Computing, Milton, Cambridge, UK) or D/R (D. L. Steffen, Biomedical Computing, Houston, TX) as described previously (Williams and Schonbrunn, 1994) and according to the method of Cheng and Prusoff (1973) .
Results
Design and characterization of a Bn receptor antagonist. Carboxyl-terminal des-methionine alkylamide and ester analogs of Bn are the most potent known antagonists for the GRP-R and exhibit Ͼ500-fold selectivity for the GRP-R relative to the neuromedin B-preferring receptor subtype (Lin et al., 1995) . Among the highest affinity compounds of this class is [D-Phe 6 ]Bn(6-13)PA (Table 1) , which inhibits Bn-stimulated amylase release from guinea pig pancreatic acini, Swiss 3T3 cell proliferation, and [ 125 ]Bn binding to the GRP-R with an EC 50 value in the nanomolar range (Wang et al., 1990) . For our studies, we needed a potent antagonist that could be radioiodinated; therefore, we synthesized a peptide in which D-Tyr was substituted for D-Phe in [D-Phe 6 ]Bn(6-13)PA. ]Bn, a less potent GRP-R antagonist (Lin et al., 1995) .
Both ]Bn(6-13) and its propylamide derivative were tested for their ability to inhibit [ 125 I-Tyr 4 ]Bn binding to HIT cells (Fig. 1) ]Bn(6-13) were all Ն200-fold less potent than Bn. The observed affinity and specificity for Bn compared with neuromedin B demonstrate that HIT cells contain the GRP-R subtype (Von Schrenck et al., 1989; Jensen and Coy, 1991) . Both of the tyrosine-substituted Bn(6-13) analogs bound to the HIT cell receptor, with the propylamide exhibiting the higher affinity.
To determine whether the [D-Tyr 6 ]Bn(6-13) derivatives functioned as antagonists, both the free acid and the propylamide were tested for inhibition of Bn-stimulated insulin secretion. As shown in Fig. 2, 3 nM Bn stimulated insulin secretion ϳ4.8-fold. In contrast, the [D-Tyr 6 ]Bn(6-13) peptides had no effect at a concentration of 10 M. However, both [D-Tyr 6 ]Bn(6-13)PA and [D-Tyr 6 ]Bn(6-13) produced a dosedependent inhibition of Bn-stimulation (Fig. 2) 
Amino acid identity with bombesin is indicated by a dashed line. PA denotes propylamide. ]Bn (Fig.  6, bottom) were removed by an acid wash. When the temperature was raised to 37°, the amount of receptor-bound antagonist that was resistant to acid did not change during a 20-min incubation (Fig. 6, top) . However, the total amount of cell-associated [ 125 I-D-Tyr 6 ]Bn(6-13)PA steadily decreased during this time and accumulated in the medium. By comparison, 55% of the receptor-bound [ 125 I-Tyr 4 ]Bn became resistant to acid dissociation within 3 min at 37° (Fig. 6, bot (Fig. 7) . Both the binding and dissociation incubations were performed in the presence or absence of chloroquine. There was no difference in the intracellular distribution of radioactivity between the control and chloroquinetreated groups with [ 125 I-D-Tyr 6 ]Bn(6-13)PA (Fig. 7A) . After 30 min at 37°, 76% of the initially bound radioactivity was released into the buffer in both groups, 20% was acid sensitive (cell surface associated), and 4% was acid resistant. (Fig. 8) , the cells were washed with HBSS containing 20 mM glycine, pH 3, which dissociates Ͼ95% of the surface-bound peptide without affecting the rebinding of ligand to the receptor (see Experimental Procedures). After this acid wash, binding of [ 125 I-Tyr 4 ]Bn to cell surface receptors was measured at 4°. The results in Fig. 8 show that pretreatment with 100 nM ]Bn(6-13)PA at 37°for up to 60 min did not decrease receptor binding. In contrast, incubation with 100 nM Bn caused a 56% reduction in binding by 5 min, and this decrease was maintained for 60 min (Fig. 8) . Therefore, unlike the agonist, receptor occupancy with the antagonist [D-Tyr 6 ]Bn(6-13)PA did not decrease cell surface receptors, demonstrating that receptor occupancy alone is not sufficient to induce receptor internalization.
Binding of Bn leads to the generation of diacylglycerol and consequently to the activation of PKC (Swope and Schonbrunn, 1988) . However, direct activation of PKC by phorbol ester treatment does not cause the internalization of unoccupied Bn receptors in HIT cells (Swope and Schonbrunn, 1990) . To determine whether activation of PKC stimulates the internalization of antagonist-occupied receptors, HIT cells were preincubated for 15 min at 37°with 100 nM PMA and then treated with 100 nM [D-Tyr 6 ]Bn(6-13)PA in the continued presence of PMA. Treatment with the combination of PMA and [D-Tyr 6 ]Bn(6-13)PA for up to 60 min did not affect cell surface receptor binding (Fig. 8) . Thus, PKC activation does not promote internalization of the antagonistoccupied receptor.
To determine whether PKC activation is necessary for receptor internalization of agonist-occupied receptors, cells were preincubated for 15 min at 37°with the PKC inhibitor 4 M GF109203X (Toullec et al., 1991) . Bn (100 nM) then was added to induce receptor internalization. After 10 min, the cells were washed with pH 3 buffer and incubated with [ 125 I-D-Tyr 6 ]Bn(6-13)PA at 4°to quantify the cell surface Cheng and Prusoff (1973) ]Bn(6-13)PA binding to the same extent in the presence and absence of GF109203X (data not shown). Because at 37°GRP-R internalization occurred very rapidly, we further examined the effect of GF109203X on receptor internalization at 30°. As shown in Fig. 9 , GF109203X decreased the rate of Bn-induced GRP-R internalization. However, after a 10-min incubation with Bn at 30°, there was no difference in cell surface receptors between the control and inhibitor groups (data not shown). These results demonstrate that activation of PKC increases the rate of agonist-induced GRP-R internalization but is not essential for induction of endocytosis.
Discussion
Both second-messenger formation and stimulation of biological responses, such as insulin secretion, desensitize rapidly in the continued presence of Bn Schonbrunn, 1987, 1990; Kroog et al., 1995a) . Agonist-induced internalization of plasma membrane receptors has been proposed to play a role in this desensitization process in HIT cells because the rate of Bn-induced receptor sequestration is identical to the rate of desensitization, both occurring within minutes of agonist binding (Swope and Schonbrunn, 1990) . Although the molecular mechanisms involved in GRP-R regulation are not known, the time course for Bn-induced receptor phosphorylation correlates with receptor internalization and desensitization (Kroog et al., 1995b; Williams et al., 1996) . Phosphorylation of the GRP-R after agonist binding is a complex process mediated by two classes of protein kinases: a 7-hydroxy-staurosporine-sensitive PKC that is activated by the diacylglycerol produced on Bn stimulation and a 7-hydroxystaurosporine-insensitive kinase, presumably a member of the GRK family (Kroog et al., 1995b; Williams et al., 1996) . GRKs are serine and threonine kinases that preferentially phosphorylate the agonist-occupied, activated conformation of seven-transmembrane-domain receptors and thereby cause receptor/G protein uncoupling and receptor endocytosis (Haga et al., 1994; Premont et al., 1995) . Phosphorylation of the GRP-R by the PKC and non-PKC mechanisms occurs at distinct sites because a receptor antibody that is unable to recognize the receptor after PMA-stimulated phosphorylation immunoprecipitates 32 PO 4 -labeled receptor after Bn treatment (Williams et al., 1996) . Antagonists do not stimulate GRP-R phosphorylation (Kroog et al., 1995b) , presumably because they neither induce the activated receptor conformation necessary for phosphorylation by GRKs nor lead to second-messenger formation. Hence, they provide useful tools to dissect the mechanisms involved in ligand-stimulated receptor internalization and sequestration.
In the current report, we show that [D-Tyr 6 ]Bn(6 -13)PA is a specific antagonist that recognizes the GRP-R with high affinity. [D-Tyr 6 ]Bn(6 -13)PA by itself did not affect insulin secretion in HIT cells; rather, it caused a dose-dependent inhibition of Bn-stimulated secretion. Its affinity for the GRP-R (K d Ϸ 3 nM) was similar to that reported for the Phe 6 analog [D-Phe 6 ]Bn(6 -13)PA (K d ϭ 4.4 nM) (Wang et al., 1990) . Binding of the radiolabeled antagonist [ 125 I-DTyr 6 ]Bn(6 -13)PA was rapid, time and temperature dependent, reversible, and saturable. Only Bn and peptides that interact with Bn receptors inhibited [ 125 I-D-Tyr 6 ]Bn(6 -13)PA binding, whereas agents that interact with other peptide receptors, such as vasoactive intestinal peptide, somatostatin, thyrotropin-releasing hormone and epidermal growth factor, had no effect. Furthermore, the affinities of the various Bn receptor agonists and antagonists calculated from competition binding studies with the antagonist [ 125 I-D-Tyr finity ligand for the GRP-R; iodination actually increases its affinity for the receptor.
We used two different assays to compare agonist-and antagonist-induced receptor internalization. First, we measured changes in the distribution of radiolabeled, receptorbound ligand using low pH to remove cell surface-associated peptide. Second, we assessed receptor sequestration by measuring cell surface binding at 4°after pretreatment with unlabeled ligand. In the first experimental situation, receptor endocytosis is being measured at low receptor occupancy under conditions where second-messenger formation is increased only slightly. In the latter paradigm, receptors are fully occupied by peptide and second-messenger production is maximally stimulated.
Unlike ]Bn(6 -13)ME was minimally internalized by GRP-Rs in other cell types (Mantey et al., 1993; Tseng et al., 1995 ]Bn(6 -13)PA is not routed through lysosomes via a receptor-mediated internalization process. Any degradation of the bound antagonist peptide must occur at the cell surface, perhaps catalyzed by plasma membrane endopeptidases (Bunnett et al., 1985) . Consistent with these results, pretreatment of HIT cells with saturating concentrations of the unlabeled antagonist did not produce receptor sequestration. As described previously (Swope and Schonbrunn, 1990 ), Bn Together, these results demonstrate that receptor activation is required for GRP-R endocytosis.
Agonist-induced receptor activation has two distinct, albeit related, consequences: the stabilization of an activated receptor conformation by bound ligand and the stimulation of second-messenger formation with consequent PKC activation in the case of PLC-coupled receptors. PKC phosphorylation has been reported to have complex and varied effects on the internalization of GPCRs depending on both the receptor and its environment. For some PLC-coupled receptors, PKC activation seems to be directly involved in agonist-induced internalization (Liles et al., 1986; Fonseca et al., 1995; Bock et al., 1997) . For other GPCRs, PKC activation does not affect receptor internalization (Hinkle and Shanshala, 1989) . Finally, PKC activation may inhibit (Hoover and Toews, 1990) or stimulate (Signoret et al., 1997) agonist-induced receptor internalization. The situation for the GRP-R is unclear even though mutant and chimeric GRP-Rs have been used to address the importance of agonist-induced second-messenger formation in receptor internalization. Two mutant GRP-Rs that do not stimulate PLC on Bn binding were found to be less effectively internalized than the wild-type receptor (Benya et al., 1994) . Similarly, a chimeric GRP-R substituted with the third cytoplasmic loop of the m3 muscarinic cholinergic receptor (BM3L) was severely impaired in both PLC activation and receptor internalization (Tseng et al., 1995) . However, the extent to which receptor endocytosis was inhibited in mutant GRP-Rs was not clearly related either to the receptor efficacy for PLC stimulation or to the ability of the agonist occupied receptor to interact with G proteins, as deduced from the sensitivity of agonist binding to Gpp(NH)p (Benya et al., 1994; Tseng et al., 1995) . For example, neither the A263E nor the R139G mutant was able to stimulate PLC, yet agonist-induced internalization of the A263E mutant was inhibited only 50%, whereas the internalization of the R139G mutant was blocked completely (Benya et al., 1994) . Surprisingly, agonist binding was sensitive to Gpp(NH)p in both mutant receptors. Guanine nucleotide inhibition of agonist binding was reduced by 60% in the R139G mutant. However, the effect of Gpp(NH)p on the A263E mutant was indistinguishable from the wild-type receptor. The observation that PMA pretreatment stimulated the internalization of both mutant receptors supported a role for PKC stimulation, as well as an agonist-induced conformational change, in GRP-R endocytosis (Benya et al., 1994) . Further support for PKC involvement was provided by the observation that mutation of a PKC consensus site in the carboxyl terminus of the GRP-R partially inhibited receptor-mediated internalization of agonist (Benya et al., 1993) . However, the relative importance of an agonist-induced conformational change and PKCcatalyzed phosphorylation for the endocytosis of the wildtype receptor remains unknown. To address this issue directly, we examined the effect of PKC activation on the internalization of the antagonist/receptor complex as well as the effect of PKC blockade on the endocytosis of the agonist/ receptor complex. Because PMA stimulates GRP-R phosphorylation (Kroog et al., 1995b; Williams et al., 1996) and 7-hydroxy-staurosporine inhibits this PMA stimulation (Kroog et al., 1995b) , either a conventional cPKC or a novel nPKC isoform must catalyze this reaction (Nishizuka, 1995) . HIT cells have been shown to contain Ca 2ϩ -phospholipid-dependent protein kinases (Lord and Ashcroft, 1984) , and Bn increases the membrane association of PKC in this cell line within 2 min (Regazzi et al., 1990) . Furthermore, PMA stimulates insulin release by HIT cells (Swope and Schonbrunn, 1988) , and this stimulation is completely blocked by staurosporine (Deeney et al., 1996) . Thus, HIT cells contain the PKC isoforms that phosphorylate the GRP-R.
We show that PMA did not promote the sequestration of the antagonist/receptor complex. This observation extends previous data showing that acute PMA treatment in the absence of any ligand does not stimulate GRP-R endocytosis either in HIT cells (Swope and Schonbrunn, 1990) or in Swiss 3T3 cells (Brown et al., 1987) . However, it remained possible that PKC activation played a role in the internalization of the agonist/receptor complex. We found that the rate but not the extent of Bn-induced GRP-R endocytosis was reduced by the PKC inhibitor GF109203X. These results demonstrate that activation of PKC is not essential for agonist-induced GRP-R endocytosis but that it increases the rate of receptor internalization.
The conclusion that PKC does not affect the extent of GRP-R internalization is not necessarily inconsistent with the study showing that mutation of a PKC phosphorylation consensus site in the GRP-R decreased the amount of receptor/ligand complex internalized at steady state (Benya et al., 1993) ; the mutation may have affected receptor phosphorylation by a different kinase, or it could have altered receptor conformation in a critical carboxyl-terminal region. The observation that TPA increased the internalization of the agonist/receptor complex for the two signaling defective GRP-R mutants (Benya et al., 1994 ) is more puzzling. Perhaps conformational changes induced by PKC phosphorylation of these mutant receptors altered their interaction with components of the endocytic machinery, an effect that either does not occur or is not as important in the case of the wild-type receptor.
Because the antagonist [D-Tyr 6 ]Bn(6 -13)PA did not elicit GRP-R endocytosis and because the extent of Bn-stimulated internalization was unaffected when PKC activation was blocked, an agonist-induced conformational change must be required for receptor sequestration. Such a conformational change may have occurred even in the signaling-deficient GRP-R mutants examined previously and allowed agonist to stimulate internalization, albeit to a lesser extent than with the wild-type receptor (Benya et al., 1994) . This hypothesis implies that the conformational change needed for receptor endocytosis differs from that needed for PLC stimulation, perhaps because different domains of the receptor are required for the molecular interactions leading to G protein coupling and internalization. Such a model would accommodate results with several GPCRs in which antagonist, as well as agonist, binding can trigger receptor endocytosis (Conchon et al., 1994; Roettger et al., 1997) .
In summary, we synthesized a new high affinity antagonist and used it to show that antagonist binding does not stimulate the internalization of the GRP-R receptor even under conditions where PKC is activated. Moreover, PKC is not essential for the agonist-induced internalization of the wildtype receptor, although it does increase the endocytic rate of the agonist/receptor complex. 
